Introducing LIVINGSCIENCES
Leading Provider of Personalised Oncology and Bio-Analytics Solutions
Efficacy
We focus on developing in vitro & in vivo models for safety and efficacy testing.
Marketing
Hub IT allows your to store, transmit and analyze data.
Consulting
Hub IT allows your to store, transmit and analyze data.
Strategy
Hub IT allows your to store, transmit and analyze data.
How does my oncologist know which treatment is best for me?
Your cancer is as different and unique as you are, but treatments today are still mostly one-size-fits-all.
The Onco-PDO® test report provides additional key data that can give your doctor insight into your tumor’s response to medication under laboratory conditions. This enables your oncologist to design a more individualized and personalized cancer treatment.
How does the Onco-PDO® test work?
Your tumor cells will grow as mini-organs in a 3-dimensional culture called PDOs (Patient-Derived Organoids). The drugs selected by your oncologist will be tested on your individual mini-organs (PDOs) in the Invitrocue laboratory. The response to each treatment will be analyzed, and the report will be provided to your oncologist in a clinically relevant time frame.
Example of Onco-PDO® test results
The Onco-PDO® report presents test results using a rainbow bar format. Each bar represents the Integrated Response Score (IRS) Summary for different drugs or drug combinations tested on the patient's tumor cells. The IRS score combines two factors: the Rx response and the apoptotic response. Scores range from 0 to 100, where 0 indicates a poor response and 100 indicates a strong response. Each drug or drug combination is listed on the left, with its corresponding IRS score shown on a color gradient from red (poor response) to green (strong response).
This comprehensive IRS provides a prediction of drug efficacy for the patient's specific tumor cells. It is important to note that the first drug tested may not always show a strong response; sometimes, the second, third, or subsequent drugs might prove more effective. By using these results, oncologists can tailor the treatment plan to include the most effective drugs, thereby improving the chances of a successful outcome while minimizing exposure to ineffective treatments.
Example of Onco-PDO® test results
The Onco-PDO® report presents test results using a rainbow bar format. Each bar represents the Integrated Response Score (IRS) Summary for different drugs or drug combinations tested on the patient's tumor cells. The IRS score combines two factors: the Rx response and the apoptotic response. Scores range from 0 to 100, where 0 indicates a poor response and 100 indicates a strong response. Each drug or drug combination is listed on the left, with its corresponding IRS score shown on a color gradient from red (poor response) to green (strong response).
This comprehensive IRS provides a prediction of drug efficacy for the patient's specific tumor cells. It is important to note that the first drug tested may not always show a strong response; sometimes, the second, third, or subsequent drugs might prove more effective. By using these results, oncologists can tailor the treatment plan to include the most effective drugs, thereby improving the chances of a successful outcome while minimizing exposure to ineffective treatments.
